Literature DB >> 18091135

Cardiovascular surveys: manual of operations.

Paola Primatesta1, Steven Allender, Paola Ciccarelli, Angela Doring, Sidsel Graff-Iversen, Jiri Holub, Salvatore Panico, Antonia Trichopoulou, W M Monique Verschuren.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death and hospitalization in both men and women in nearly all countries of Europe. The most frequent forms of CVD are those of an atherosclerotic origin, mainly ischaemic heart disease, stroke and heart failure. The magnitude of the problem contrasts with the usual paucity and poor quality of data available on incidence and prevalence of CVD, except for few rigorous but limited studies. The objectives of the health interview and health examination surveys (HIS/HES) are to evaluate the frequency and the distribution of the disease, to evaluate trends and treatment effectiveness, to estimate risk factors distribution and prevalence of high risk conditions and to monitor prevention programmes. According to the EUROCISS project (EUROpean Cardiovascular Surveillance Set) recommendations, surveys are aimed at describing the prevalence of the following CVD conditions: myocardial infarction, heart failure, angina pectoris, peripheral arterial disease, stroke, and ischaemic heart disease.HIS and HES were developed to supplement information collected from routine databases and population-based registers to implement consistent public health policies. HIS can be repeated periodically in a new sample of the population, or can follow up over time the population recruited at baseline. Procedures and methods to collect information from participants include self-administered questionnaires, direct interviewer-administered questions and telephone interviews. A minimum set of questions to be administered every year, along with a longer, more detailed module to be administered periodically are recommended to evaluate CVD prevalence. The addition of HES provides more detailed and objective information that can be used to improve estimates regarding prevalence of both risk factors and disease status. The selection of more specialized CVD-specific tests will depend on the objective the survey is designed to achieve, the assumed response rate and the cost and time considerations. For HES on CVD the minimum required is to perform the following measurements: height, weight, blood pressure, waist circumference, total and high density lipoprotein-cholesterol and glucose assay in a nonfasting blood sample. The next appropriate step would be to perform an electrocardiogram. High costs usually make HES difficult to carry out. Standardization of measurements, training of personnel and quality control are essential to assure reliable data. A high response rate is extremely important, as nonrespondents tend to have different health characteristics from the rest of the sample and their omission therefore results in bias. This manual of operations is intended for health professionals and policy makers and provides a standardized and simple model for the implementation of a CVD survey.

Entities:  

Mesh:

Year:  2007        PMID: 18091135     DOI: 10.1097/01.hjr.0000277988.18096.3b

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  9 in total

1.  Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach.

Authors:  Robert Y L Zee; Sherri E Michaud; Soren Germer; Paul M Ridker
Journal:  Clin Chim Acta       Date:  2009-02-13       Impact factor: 3.786

2.  Prediction of asymptomatic carotid artery stenosis in the general population: identification of high-risk groups.

Authors:  Marjolein de Weerd; Jacoba P Greving; Bo Hedblad; Matthias W Lorenz; Ellisiv B Mathiesen; Daniel H O'Leary; Maria Rosvall; Matthias Sitzer; Gert Jan de Borst; Erik Buskens; Michiel L Bots
Journal:  Stroke       Date:  2014-07-03       Impact factor: 7.914

Review 3.  Monocytes in atherosclerosis: subsets and functions.

Authors:  Kevin J Woollard; Frederic Geissmann
Journal:  Nat Rev Cardiol       Date:  2010-01-12       Impact factor: 32.419

4.  The effects of trinitroglycerin injection on early complications of angiography.

Authors:  Ramin Heidari; Masoumeh Sadeghi; Hamid Sanei; Katayuon Rabiei; Mansour Shiri
Journal:  ARYA Atheroscler       Date:  2012

Review 5.  Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time.

Authors:  K Lokuge; D D de Waard; A Halliday; A Gray; R Bulbulia; B Mihaylova
Journal:  Br J Surg       Date:  2017-12-04       Impact factor: 6.939

6.  Prevalence of cardiovascular morbidities in Myanmar.

Authors:  Ko Ko Zaw; Nwe Nwe; Su Su Hlaing
Journal:  BMC Res Notes       Date:  2017-02-15

7.  European health examination surveys - a tool for collecting objective information about the health of the population.

Authors:  Hanna Tolonen; Päivikki Koponen; Ala'a Al-Kerwi; Nada Capkova; Simona Giampaoli; Jennifer Mindell; Laura Paalanen; Maria Ruiz-Castell; Antonia Trichopoulou; Kari Kuulasmaa
Journal:  Arch Public Health       Date:  2018-06-28

8.  Cardiovascular diseases monitoring: lessons from population-based registries to address future opportunities and challenges in Europe.

Authors:  Luigi Palmieri; Giovanni Veronesi; Giovanni Corrao; Giuseppe Traversa; Marco M Ferrario; Giovanni Nicoletti; Anna Di Lonardo; Chiara Donfrancesco; Flavia Carle; Simona Giampaoli
Journal:  Arch Public Health       Date:  2018-06-28

9.  Carotid artery stenting, endarterectomy, or medical treatment alone: the debate is not over.

Authors:  Seyed Ebrahim Kassaian; Hamidreza Goodarzynejad
Journal:  J Tehran Heart Cent       Date:  2011-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.